Principle Investigators should apply for fellowship funding to support clinical (Grade E64) or basic research scientists (Grade 7/8) committed to translational science and interested in obtaining experience with drug development in an industrial setting.
Fellowship applications may include a named fellow, but this is not mandatory. It is expected that a suitable fellowship candidate will be identified by the Principle Investigator within 6 months of notification of successful project selection.
The proposed fellowship needs to align with BMS’s fields of interest as listed below.
1. Novel targets, biomarkers, cellular therapeutic approaches, or translational models in one of the following areas:
- neurodegenerative and neuroinflammatory diseases including Alzheimer’s, Parkinson’s, ALS, FTD and MS;
- fibrosing disorders including IPF, NASH, scleroderma, and Renal Fibrosis;
- rheumatic and dermatologic disorders including RA, SLE, spondyloarthropathies, psoriasis and atopic dermatitis;
- haematologic disorders including AML, Myeloma, DLBCL;
- chronic heart failure (either with preserved or reduced ejection fraction).
2. Methods for evaluating biochemical, cellular, tissue and phenotypic consequences of
modulating epigenetic targets.
3. Methods for immuno-phenotyping of human subjects in oncology and autoimmunity
4. Novel imaging approaches to measuring disease activity in the above areas.